Phase 2 Alzheimer Disease (AD) trials recruiting now

All Alzheimer Disease (AD) trials, every phase

Phase 2 Alzheimer Disease (AD) trials

• Daridorexant for Alzheimer Disease Prevention
  NCT07213349 · Phase: Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease
  NCT07741071 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 2 locations
• Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
  NCT05395624 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 9 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.